Evonik baut Produktionskapazitäten für lipidbasierte Wirkstoffe in Vancouver aus

Lipid nanoparticlesPositive

AI Analysis

Summary

Evonik is expanding lipid nanoparticle production capacity in Vancouver with investment of over 150 million CAD, supported by Canadian government funding, to meet growing demand for lipid-based drug development and clinical manufacturing.

Importance:3/10

Sentiment:

0.60

manufacturingcapacity expansionlipid nanoparticlesCanadaGMP facilitygovernment funding

Read the original article

Published by PR Newswire Pharma on August 28, 2026 7:00 AM

Read Original